Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1 Beta Interacts with Nucleoporin 62 To Promote Viral Replication and Immune Evasion.

Ke H, Han M, Kim J, Gustin KE, Yoo D.

J Virol. 2019 Jun 28;93(14). pii: e00469-19. doi: 10.1128/JVI.00469-19. Print 2019 Jul 15.

PMID:
31043527
2.

Proteolysis of MDA5 and IPS-1 is not required for inhibition of the type I IFN response by poliovirus.

Kotla S, Gustin KE.

Virol J. 2015 Oct 6;12:158. doi: 10.1186/s12985-015-0393-2.

3.

Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).

Park N, Schweers NJ, Gustin KE.

J Virol. 2015 Nov;89(21):11069-79. doi: 10.1128/JVI.00956-15. Epub 2015 Aug 26.

4.

Persistent human rhinovirus type C infection of the lower respiratory tract in a pediatric cord blood transplant recipient.

Pathak AK, Adams RH, Shah NC, Gustin KE.

Bone Marrow Transplant. 2013 May;48(5):747-8. doi: 10.1038/bmt.2012.226. Epub 2012 Nov 19. No abstract available.

PMID:
23165503
5.

Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease.

Park N, Skern T, Gustin KE.

J Biol Chem. 2010 Sep 10;285(37):28796-805. doi: 10.1074/jbc.M110.143404. Epub 2010 Jul 9.

6.

Stable formation of compositionally unique stress granules in virus-infected cells.

Piotrowska J, Hansen SJ, Park N, Jamka K, Sarnow P, Gustin KE.

J Virol. 2010 Apr;84(7):3654-65. doi: 10.1128/JVI.01320-09. Epub 2010 Jan 27.

7.

Rapid detection and quantitation of poliovirus and rhinovirus sequences in viral stocks and infected cells.

Kotla S, Major SC, Gustin KE.

J Virol Methods. 2009 Apr;157(1):32-9. doi: 10.1016/j.jviromet.2008.12.005. Epub 2009 Jan 16.

8.

Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein.

Ricour C, Delhaye S, Hato SV, Olenyik TD, Michel B, van Kuppeveld FJ, Gustin KE, Michiels T.

J Gen Virol. 2009 Jan;90(Pt 1):177-86. doi: 10.1099/vir.0.005678-0.

9.

Utilization of solid nanomaterials for drug delivery.

Beaux MF 2nd, McIlroy DN, Gustin KE.

Expert Opin Drug Deliv. 2008 Jul;5(7):725-35. doi: 10.1517/17425247.5.7.725 . Review.

PMID:
18590458
10.

Attenuation of the type I interferon response in cells infected with human rhinovirus.

Kotla S, Peng T, Bumgarner RE, Gustin KE.

Virology. 2008 May 10;374(2):399-410. doi: 10.1016/j.virol.2008.01.022. Epub 2008 Feb 12.

11.

Differential targeting of nuclear pore complex proteins in poliovirus-infected cells.

Park N, Katikaneni P, Skern T, Gustin KE.

J Virol. 2008 Feb;82(4):1647-55. Epub 2007 Nov 28.

12.

Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Peng T, Kotla S, Bumgarner RE, Gustin KE.

J Virol. 2007 Jun;81(11):6161. No abstract available.

13.

Differential sensitivity of viruses to the antiviral activity of Shiga toxin 1 A subunit.

Ferens WA, Halver M, Gustin KE, Ott T, Hovde CJ.

Virus Res. 2007 Apr;125(1):104-8. Epub 2007 Jan 2.

PMID:
17197049
14.

Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Peng T, Kotla S, Bumgarner RE, Gustin KE.

J Virol. 2006 May;80(10):5021-31. Erratum in: J Virol. 2006 Jul;80(13):6722. Retraction in: Peng T, Kotla S, Bumgarner RE, Gustin KE. J Virol. 2007 Jun;81(11):6161.

15.
16.

Proteolytic cleavage of the catalytic subunit of DNA-dependent protein kinase during poliovirus infection.

Graham KL, Gustin KE, Rivera C, Kuyumcu-Martinez NM, Choe SS, Lloyd RE, Sarnow P, Utz PJ.

J Virol. 2004 Jun;78(12):6313-21.

17.
18.
19.
20.
21.
22.

A rapid method for generating linker scanning mutants utilizing PCR.

Gustin KE, Burk RD.

Biotechniques. 1993 Jan;14(1):22, 24. No abstract available.

PMID:
8424870

Supplemental Content

Loading ...
Support Center